Literature DB >> 22157244

New clinical and histological patterns of acute disseminated histoplasmosis in human immunodeficiency virus-positive patients with acquired immunodeficiency syndrome.

Jose E Ollague Sierra1, Jose M Ollague Torres.   

Abstract

Histoplasmosis has attained increasing relevance in the past 3 decades because of the appearance of the human immunodeficiency virus (HIV). In most immunocompetent persons, the infection is asymptomatic or can produce a respiratory condition with symptoms and radiological images similar to those observed in pulmonary tuberculosis; in non-HIV+ immunocompromised patients, it can cause respiratory symptoms or evolve into a disseminated infection. The same can occur in acquired immunodeficiency syndrome (AIDS) patients. We have observed a series of HIV+ patients with AIDS who presented with cutaneous histoplasmosis and in whom the clinical and histopathological features were highly unusual, including variable mucocutaneous lesions that were difficult to diagnose clinically. These patients displayed unusual, previously undescribed, histological patterns, including lichenoid pattern, nodular pseudomyxoid pattern, pyogenic granuloma-like pattern, perifollicular pattern, and superficial (S), mid (M), and deep perivascular dermatitis; and more commonly encountered patterns, such as histiocytic lobular panniculitis and focal nodular dermatitis. The novel histopathological patterns of cutaneous involvement by histoplasmosis seen in these patients resembled other common inflammatory and infectious conditions and required a high level of suspicion and the application of special stains for organisms for confirmation. These new, clinical, and histological findings do not seem to be commonly encountered in HIV- patients infected with the fungus but seem to be displayed most prominently in HIV+ patients with AIDS.

Entities:  

Mesh:

Year:  2013        PMID: 22157244     DOI: 10.1097/DAD.0b013e31822fd00a

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  7 in total

1.  Diagnostic Methods for Histoplasmosis: Focus on Endemic Countries with Variable Infrastructure Levels.

Authors:  Christina M Scheel; Beatriz L Gómez
Journal:  Curr Trop Med Rep       Date:  2014-04-08

2.  Progressive disseminated histoplasmosis in children living with HIV: a case series study.

Authors:  Miguel García-Boyano; Greta Miño-León; William Vega; Luis Prieto; Nelly Chávez-Solórzano; Dalton Solís Montiel
Journal:  Eur J Pediatr       Date:  2021-02-08       Impact factor: 3.183

3.  Serious fungal infections in Ecuador.

Authors:  J Zurita; D W Denning; A Paz-Y-Miño; M B Solís; L M Arias
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-04       Impact factor: 3.267

4.  ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.

Authors:  Deniz Cagdas; Pınar Gur Cetinkaya; Betül Karaatmaca; Saliha Esenboga; Cagman Tan; Togay Yılmaz; Ersin Gümüş; Safa Barış; Barış Kuşkonmaz; Tuba Turul Ozgur; Pawan Bali; Ines Santisteban; Diclehan Orhan; Aysel Yüce; Duygu Cetinkaya; Kaan Boztug; Michael Hershfield; Ozden Sanal; İlhan Tezcan
Journal:  J Clin Immunol       Date:  2018-05-09       Impact factor: 8.317

5.  Colonic involvement in disseminated histoplasmosis of an immunocompetent adult: case report and literature review.

Authors:  Biwei Yang; Lixia Lu; Dajiang Li; Li Liu; Libin Huang; Liyu Chen; Hong Tang; Lichun Wang
Journal:  BMC Infect Dis       Date:  2013-03-20       Impact factor: 3.090

Review 6.  Detection of microorganisms in granulomas that have been formalin-fixed: review of the literature regarding use of molecular methods.

Authors:  Jeannette Guarner
Journal:  Scientifica (Cairo)       Date:  2012-12-31

Review 7.  Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature.

Authors:  Paola Zanotti; Claudia Chirico; Maurizio Gulletta; Laura Ardighieri; Salvatore Casari; Eugenia Quiros Roldan; Ilaria Izzo; Gabriele Pinsi; Giovanni Lorenzin; Fabio Facchetti; Francesco Castelli; Emanuele Focà
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-07-01       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.